CARM1 and cancer: In brief, we used integrated bioinformatics approaches, and the obtained results revealed that CARM1 expression may enhance immune infiltration and influence the survival rate of patients in pancancer, suggesting that CARM1 can be used as a prognostic biomarker and may provide knowledge to explore the malignancies and their pathologic processes of those prevalent cancers.